A phase 3 pivotal trial of AGB101 to slow progression in MCI due to alzheimer's disease
Ended Project Grant Awarded Last action
- Award ID
- R01AG061091
- Recipient
-
Agenebio, Inc. UEI YZWJGZMT3MN5
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $35,532,475
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Funding
-
- $32,687,640.88 Federal
- $2,844,834.00 Non-federal
- Place of performance
- Maryland, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | -$724,077 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $0 | $0 | |
| Amendment | $1,595,216 | $0 | |
| Amendment | $1,595,216 | $0 | |
| Amendment | $1,595,216 | $0 | |
| Amendment | $1,595,216 | $0 | |
| Amendment | $1,595,216 | $0 | |
| Amendment | $2,844,834 | $0 | |
| Amendment | $2,844,834 | $2,844,834 | |
| Amendment | $0 | $0 | |
| Amendment | $4,903,985 | $0 | |
| Amendment | $4,942,354 | $0 | |
| Amendment | $4,948,571 | $0 | |
| Amendment | $0 | $0 | |
| Original award | $4,951,060 | $0 |
Show all 22
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Johns Hopkins University | $2,119,450 |
Quick answers
Who received award R01AG061091?
R01AG061091 was awarded to Agenebio, Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2018.
How much is award R01AG061091 worth?
$35,532,475 has been obligated on R01AG061091: $32,687,641 in federal funding and $2,844,834 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award